Support

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:19

Aditya Shetty

Written by
Sunday, 08 August 2021 11:19

Tobias Eggert

Written by
Sunday, 08 August 2021 11:19

Steven Dubinett

Written by
Steve Dubinett first became interested in lung cancer immunology research while a pulmonary research fellow in the Department of Pathology at Massachusetts General Hospital. There he took part in the first clinical trial using tumor-infiltrating lymphocytes to treat patients with cancer. While some of the patients with renal cancer and melanoma had very dramatic anti-tumor responses, the patients with lung cancer did not respond to the therapy. After moving to UCLA in 1988, he began his research program focusing on understanding why lung cancer patients were not responding to immunotherapy. This has led to research related to immunity and inflammation in the early pathogenesis of lung cancer, currently funded by Stand Up to Cancer-LUNGevity-ALA Dream Team in Lung Cancer Interception, the NCI Human Tumor Atlas Network, NCI Early Detection Research Network, NCI Molecular Characterization Laboratory Program, the VA Lung Precision Oncology Program, and the California Institute for Regenerative Medicine. He has trained more than 50-graduate students, post-doctoral fellows and junior faculty, nearly all of whom have continued in academic or industry research careers. He is the UCLA Associate Vice Chancellor for Research and the Senior Associate Dean for Translational Research for the David Geffen School of Medicine at UCLA. He has led the UCLA Clinical and Translational Science Institute since 2010.
Sunday, 08 August 2021 11:19

David Elashoff

Written by
Sunday, 08 August 2021 11:19

Shahyar Ashouri

Written by
Sunday, 08 August 2021 11:19

Kanwarpal Kahlon

Written by
Sunday, 08 August 2021 11:19

Anita Kaul

Written by
Sunday, 08 August 2021 11:19

Gregory Fishbein

Written by
Sunday, 08 August 2021 11:19

Zhe Jing

Written by
Page 152 of 371